Warnes A, Brown M R, Fooks A R, Shuttleworth H, Dowsett A B, Melling J, Stephenson J R
PHLS Centre for Applied Microbiology and Research, Salisbury, UK.
Curr Microbiol. 1993 Jun;26(6):337-44. doi: 10.1007/BF01576266.
Protein A from Staphylococcus aureus is a powerful diagnostic reagent and has several uses in human disease therapy. Expression in non-pathogenic Escherichia coli containing recombinant plasmids coding for this protein has increased its availability, but can reduce the stability of the plasmid-bearing host. By employing immune electron microscopy, we have determined that E. coli containing stable plasmids coding for a truncated version of protein A, without the membrane binding site, secrete this protein through the cytoplasmic membrane and into the periplasmic space, where it accumulates. E. coli containing unstable plasmids, however, which code for the complete protein including the membrane-binding site, target the protein into the cytoplasmic membrane. This accumulation of protein A in the E. coli cytoplasmic membrane inhibits the formation of septa between dividing cells and results in aberrant elongated, multi-chromosomal forms.
金黄色葡萄球菌的蛋白A是一种强大的诊断试剂,在人类疾病治疗中有多种用途。在含有编码该蛋白的重组质粒的非致病性大肠杆菌中表达,提高了其可用性,但可能会降低携带质粒宿主的稳定性。通过免疫电子显微镜,我们已经确定,含有编码无膜结合位点的截短型蛋白A的稳定质粒的大肠杆菌,会将这种蛋白分泌穿过细胞质膜进入周质空间,并在那里积累。然而,含有编码包括膜结合位点在内的完整蛋白的不稳定质粒的大肠杆菌,会将该蛋白靶向到细胞质膜中。蛋白A在大肠杆菌细胞质膜中的这种积累会抑制分裂细胞之间隔膜的形成,并导致异常的细长、多染色体形态。